n,n-dimethylarginine has been researched along with allantoin in 2 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (allantoin) | Trials (allantoin) | Recent Studies (post-2010) (allantoin) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 1,130 | 70 | 257 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckmann, B; Bode-Böger, SM; Borlak, J; Martens-Lobenhoffer, J; Scalera, F; Täger, M; Thum, T | 1 |
| Carru, C; Ena, S; Mangoni, AA; Satta, AE; Sotgia, S; Sotgiu, E; Zinellu, A | 1 |
2 other study(ies) available for n,n-dimethylarginine and allantoin
| Article | Year |
|---|---|
Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence.
Topics: Allantoin; Amidohydrolases; Arginine; Cells, Cultured; Cellular Senescence; Chemokine CCL2; Endothelial Cells; Enzyme Inhibitors; Flow Cytometry; Humans; Immunophenotyping; Interleukin-8; Nitric Oxide Synthase; Oxidative Stress; S-Adenosylhomocysteine; Telomerase; Umbilical Veins | 2004 |
Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease.
Topics: Allantoin; Anticholesteremic Agents; Arginine; Biomarkers; Cholesterol; Endothelium; Ezetimibe; Female; Humans; Inflammation; Kynurenine; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Insufficiency, Chronic; Simvastatin; Uric Acid | 2016 |